Covid-19 Member Announcements & News

 


CanSino Biologics and Precision NanoSystems Announce – Collaboration to Co-Develop a COVID-19 RNA Vaccine

Tianjin, China and Vancouver, Canada – CanSino Biologics Inc. (CanSinoBIO, HK6185) and Precision NanoSystems (PNI) today announced a co-development agreement of a mRNA lipid nanoparticle (mRNA-LNP) vaccine against COVID-19.


NRC – IRAP EUREKA Call for Proposal by May 15, 2020

CIIP is pleased to announce its collaboration with NRC-IRAP on the EUREKA call for proposal. This call for proposals for joint research and development (R&D) projects addressing short to medium term solutions for COVID-19 difficulties is now open to Canadian small and medium-sized enterprises…


Variational AI Receives Support from the Digital Technology Supercluster for Repurposing of Drugs for COVID-19

Variational AI Inc. is pleased to announce a new project using their novel artificial intelligence technology to rapidly identify existing drugs with a high probability of being efficacious in combatting COVID-19…


STEMCELL Technologies Is an Essential Industry Partner for COVID-19 Research and Vaccine Development

Products made by Vancouver’s STEMCELL Technologies are now being used in over 30 COVID-19 studies worldwide. These studies are focusing on areas ranging from diagnostics and treatments to vaccine development and future prevention…


MSFHR Launches COVID-19 Research Response Fund & First Call For Proposals

The MSFHR COVID-19 Research Response Fund opens today (April 6) with the first of several funding calls for BC researchers. Researchers or research teams interested in applying to this first call should have projects that address one or more of the following…


Roche COVID-19 Open Innovation Challenge

The SARS-CoV-2 (COVID-19) pandemic is impacting the daily lives of everyone around the world. We are isolated within our communities, we are exceeding the capacity of our health systems, and we are struggling to keep pace with the rapidness of the outbreak…


Innovative Medicines Canada members donate 100,000 masks to help protect front-line healthcare workers battling COVID-19

Members of Innovative Medicines Canada (IMC) are continuing their efforts in the fight against COVID-19 by donating 100,000 N95 masks for front-line healthcare workers battling the virus…


Global Biotechnology Firm STEMCELL Launches COVID-19 Staff Safety App

OutSystems announced that STEMCELL Technologies has launched its “My Status” app to help keep STEMCELL staff safe during the COVID-19 pandemic…


Xenon Pharmaceuticals Provides Corporate Update in the Context of COVID-19

Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today provided a corporate update in the context of the developing situation with the COVID-19 pandemic…


Curiox Biosystems and STEMCELL Technologies Announce Method to Safely Prepare COVID-19 Blood Samples for Vaccine Research

Curiox Biosystems in conjunction with STEMCELL Technologies today announced a new system that will help researchers develop vaccines to SARS-CoV-2, the virus that causes COVID-19…


Bold Therapeutics Seeks Collaborators for Rapid Development of BOLD-100; Lead Drug Candidate Has Potential Utility in the Treatment of COVID-19

Bold Therapeutics, a clinical-stage biopharmaceutical company developing novel anti-cancer therapies, announced that recent developments have suggested the potential utility of its lead drug BOLD-100 as a novel antiviral agent…


Genome BC Launches Rapid Response Funding for COVID-19 Projects

 Genome BC is today launching a rapid response funding program to invest in promising research and innovation projects with the real potential to address urgent challenges related to the COVID-19 pandemic…


Canadian Biotechnology Company STEMCELL Technologies Provides Critical Support to Sequence the COVID-19 Virus, Accelerating Vaccine Development

Canada’s largest biotechnology company, Vancouver’s STEMCELL Technologies, has been making significant contributions to the fight against COVID-19…


COVID-19: life sciences working together on a solution

The global outbreak of the novel coronavirus (COVID-19) is an issue of growing concern around the world. The innovative pharmaceutical industry is working around the clock to find solutions to treat those infected by the virus and to prevent it from spreading.


Statement on Canada’s Drug Supply

As Canada responds to the global COVID-19 pandemic, some Canadians have expressed concern that they may not have access to the medicines they need, when they need them…


AbCellera and Lilly to Co-develop Antibody Therapies for the Treatment of COVID-19

AbCellera and Eli Lilly and Company (NYSE: LLY) announced today they have entered into an agreement to co-develop antibody products for the treatment and prevention of COVID-19…